Arrayjet’s patented spot-on-spot microarray screening technology is available for customers to adopt in-house and via Arrayjet’s CRO/CMO services Immunome signs deal to use Arrayjet platform in its in ...
Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that its ArrayPlexâ„¢ discovery platform has been selected by Immunome, Inc. (NASDAQ: IMNM), a biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback